ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

Larry Norton Is President-Elect Of ASCO; Rauscher Is Cancer Research Editor-In-Chief.

March 3, 2000

Arthur Upton New Name In Director Race; Califano Meets With Prospects

May 6, 1977

ASCO Report Urges 5% Annual Increase For NIH.

December 8, 2006

NCI Breast Tissue Registry Available To Researchers

March 24, 1995